FindTrial
Sign In

A study to evaluate the effectiveness of homoepathic medicines in chronic lumbago.

A prospective observational study to evaluate the effectiveness of individualized homoepathic medicines in chronic lumbago.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040224
Enrollment
44
Registered
2022-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M545- Low back pain

Interventions

Control Intervention1: Nil: Nil

Sponsors

Stuti Rastogi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from lumbago of duration of at least three months. Patients coming from another mode of treatment willing to take Homoeopathic treatment with washout period of 10 days.

Exclusion criteria

Exclusion criteria: Pregnant women Females in the period of 6 months after delivery. Systemic diseases with gross pathology like HIV, malignancy

Design outcomes

Primary

MeasureTime frame
To assess the role of individualized homoeopathic medicines in the cases of chronic lumbago by using Oswerstry Low Back Pain scale. Timepoint: Pre and post scale will be applied at the baseline and at the end of three months.—

Secondary

MeasureTime frame
Prepare a therapeutic compendium of homoeopathic medicines for the management of chronic lumbago. Timepoint: List of the most indicated homoeopathic medicines for chronic lumbago will be formed in 1 year of study duration.—

Countries

India

Contacts

Public ContactDr Yogeshwari Gupta

Swasthya Kalyan Homoeopathic Medical College and Research Center

principalskhmc@gmail.com9414229555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026